BIO-key International, Inc. announced that it received a notification from Nasdaq on April 17, 2025, regarding its failure to timely file its Annual Report for the year ended December 31, 2024, which ...
Hosted on MSN
Bio-Path Holdings Delays 10-Q Filing
Bio-Path Holdings ( (BPTH)) has released a notification of late filing. Bio-Path Holdings, Inc. has announced a delay in filing its Form 10-Q (Quarter Report) for the financial period ending September ...
Announced positive preliminary safety and efficacy data from Phase 1 clinical trial of ADI-001 in patients with lupus nephritis (LN) and systemic lupus erythematosus (SLE); data highlighted rapid and ...
-- Cash and cash equivalents of $49.0 million as of September 30, 2025 expected to provide financial runway into 2027 -- WALTHAM, Mass., Nov. 13, 2025 /PRNewswire/ -- Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 ...
SOUTH SAN FRANCISCO, Calif., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology company developing next-generation cell and gene ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--2seventy bio, Inc. (Nasdaq: TSVT), today reported financial results and recent highlights for the fourth quarter and full year ended December 31, 2024. “2024 was a ...
VCAR33 clinical data update planned for first half of 2025 and trem-cel + Mylotarg clinical data update planned for second half of 2025 Anticipate initiation of the first trem-cel+VCAR33 Treatment ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback